On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q1 2024 earnings per share (EPS) of $1.35, up 4,600% year over year. Total Johnson & Johnson earnings for the quarter were $3.26 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was -$0.03.
As of Q2 2024, Johnson & Johnson's earnings has grown 215.29% year over year. This is 195.67 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 19.62%. Johnson & Johnson's earnings in the past year totalled $38.48 billion.
What is JNJ's earnings date?
Johnson & Johnson's earnings date is Invalid Date. Add JNJ to your watchlist to be reminded of JNJ's next earnings announcement.
What was JNJ's revenue last quarter?
On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q1 2024 revenue of $21.38 billion up 2.34% year over year. In the same quarter last year, Johnson & Johnson's revenue was $20.89 billion.
What was JNJ's revenue growth in the past year?
As of Q2 2024, Johnson & Johnson's revenue has grown 5.6% year over year. This is 3.25 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.85%. Johnson & Johnson's revenue in the past year totalled $81.80 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.